![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Excellent Results for MS Drug Plegridy
Excellent Results for MS Drug Plegridy
March 21, 2013
Biogen Idec has just announced its final first year results of the Phase III trial of its relapsing-remitting multiple sclerosis drug Plegridy. The drug met all primary and secondary endpoints of the trial results indicating that it is very effective at reducing multiple sclerosis (MS) disease activity.
Medical News Today
Medical News Today
Upcoming Events
-
21Oct